Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference116 articles.
1. Alzheimer’s Disease International. World Alzheimer Report 2015: the global impact of dementia. An analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International (ADI), London; 2015.
2. Prince M, Bryce R, Albanese E, Wimo A, Ribiero W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63–75.
3. Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008;148(5):379–97.
4. Wong CW. Pharmacotherapy for dementia: a practical approach to the use of cholinesterase inhibitors and memantine. Drugs Aging. 2016. doi: 10.1007/s40266-016-0372-3 .
5. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet. 1976;2(8000):1403.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-dementia drugs: what is the evidence in advanced stages?;Porto Biomedical Journal;2024-03
2. Tratamiento del deterioro cognitivo;Medicine - Programa de Formación Médica Continuada Acreditado;2023-03
3. Psychopharmacology;The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry;2022-08-09
4. Prescribing in Older People;The Maudsley Prescribing Guidelines in Psychiatry;2021-12-17
5. Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients;American Journal of Hospice and Palliative Medicine®;2020-07-14